GALERA THERAPEUTICS, INC. (GRTX): Price and Financial Metrics
GRTX Price/Volume Stats
| Current price | $0.03 | 52-week high | $0.29 |
| Prev. close | $0.03 | 52-week low | $0.02 |
| Day low | $0.03 | Volume | 211,900 |
| Day high | $0.03 | Avg. volume | 1,084,161 |
| 50-day MA | $0.05 | Dividend yield | N/A |
| 200-day MA | $0.11 | Market Cap | 1.69M |
GRTX Stock Price Chart Interactive Chart >
GALERA THERAPEUTICS, INC. (GRTX) Company Bio
Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
GRTX Price Returns
| 1-mo | -25.19% |
| 3-mo | -62.03% |
| 6-mo | -74.45% |
| 1-year | -77.19% |
| 3-year | -99.29% |
| 5-year | -99.78% |
| YTD | -79.37% |
| 2023 | -90.24% |
| 2022 | -67.54% |
| 2021 | -55.13% |
| 2020 | -22.26% |
| 2019 | N/A |
Loading social stream, please wait...